Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 71, 9, (2169-2181), 10.1007/s00262-022-03151-2)

Mitchell S. von Itzstein; Amrit S. Gonugunta; Yiqing Wang; Thomas Sheffield; Rong Lu; Sadia Ali; Farjana J. Fattah; Donglu Xie; Jennifer Cai; Yang Xie; David E. Gerber

doi:10.1007/s00262-022-03218-0

Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 71, 9, (2169-2181), 10.1007/s00262-022-03151-2)

Mitchell S. von Itzstein, Amrit S. Gonugunta, Yiqing Wang, Thomas Sheffield, Rong Lu, Sadia Ali, Farjana J. Fattah, Donglu Xie, Jennifer Cai, Yang Xie, David E. Gerber

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

The article Divergent prognostic effects of pre‑existing and treatment‑emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors, written by Mitchell S. von Itzstein, Amrit S. Gonugunta, Yiqing Wang, Thomas Sheffield, Rong Lu, Sadia Ali, Farjana J. Fattah, Donglu Xie, Jennifer Cai, Yang Xie and David E. Gerber, was originally published electronically on the publisher’s internet portal on 24 January 2022 without open access.

Original language	English (US)
Pages (from-to)	2183-2184
Number of pages	2
Journal	Cancer Immunology, Immunotherapy
Volume	71
Issue number	9
DOIs	https://doi.org/10.1007/s00262-022-03218-0
State	Published - Sep 2022

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Oncology
Cancer Research

Access to Document

10.1007/s00262-022-03218-0

Fingerprint

Dive into the research topics of 'Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 71, 9, (2169-2181), 10.1007/s00262-022-03151-2)'. Together they form a unique fingerprint.

Cite this

von Itzstein, M. S., Gonugunta, A. S., Wang, Y., Sheffield, T., Lu, R., Ali, S., Fattah, F. J., Xie, D., Cai, J., Xie, Y., & Gerber, D. E. (2022). Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 71, 9, (2169-2181), 10.1007/s00262-022-03151-2). Cancer Immunology, Immunotherapy, 71(9), 2183-2184. https://doi.org/10.1007/s00262-022-03218-0

Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 71, 9, (2169-2181), 10.1007/s00262-022-03151-2). / von Itzstein, Mitchell S.; Gonugunta, Amrit S.; Wang, Yiqing et al.
In: Cancer Immunology, Immunotherapy, Vol. 71, No. 9, 09.2022, p. 2183-2184.

Research output: Contribution to journal › Comment/debate › peer-review

von Itzstein, MS, Gonugunta, AS, Wang, Y, Sheffield, T, Lu, R, Ali, S , Fattah, FJ, Xie, D, Cai, J, Xie, Y & Gerber, DE 2022, 'Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 71, 9, (2169-2181), 10.1007/s00262-022-03151-2)', Cancer Immunology, Immunotherapy, vol. 71, no. 9, pp. 2183-2184. https://doi.org/10.1007/s00262-022-03218-0

von Itzstein MS, Gonugunta AS, Wang Y, Sheffield T, Lu R, Ali S et al. Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 71, 9, (2169-2181), 10.1007/s00262-022-03151-2). Cancer Immunology, Immunotherapy. 2022 Sep;71(9):2183-2184. doi: 10.1007/s00262-022-03218-0

von Itzstein, Mitchell S. ; Gonugunta, Amrit S. ; Wang, Yiqing et al. / Correction to : Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 71, 9, (2169-2181), 10.1007/s00262-022-03151-2). In: Cancer Immunology, Immunotherapy. 2022 ; Vol. 71, No. 9. pp. 2183-2184.

@article{133c136c8978498fbad9692d3a96e44d,

title = "Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 71, 9, (2169-2181), 10.1007/s00262-022-03151-2)",

abstract = "The article Divergent prognostic effects of pre‑existing and treatment‑emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors, written by Mitchell S. von Itzstein, Amrit S. Gonugunta, Yiqing Wang, Thomas Sheffield, Rong Lu, Sadia Ali, Farjana J. Fattah, Donglu Xie, Jennifer Cai, Yang Xie and David E. Gerber, was originally published electronically on the publisher{\textquoteright}s internet portal on 24 January 2022 without open access.",

author = "{von Itzstein}, {Mitchell S.} and Gonugunta, {Amrit S.} and Yiqing Wang and Thomas Sheffield and Rong Lu and Sadia Ali and Fattah, {Farjana J.} and Donglu Xie and Jennifer Cai and Yang Xie and Gerber, {David E.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = sep,

doi = "10.1007/s00262-022-03218-0",

language = "English (US)",

volume = "71",

pages = "2183--2184",

journal = "Cancer Immunology, Immunotherapy",

issn = "0340-7004",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "9",

}

TY - JOUR

T1 - Correction to

T2 - Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 71, 9, (2169-2181), 10.1007/s00262-022-03151-2)

AU - von Itzstein, Mitchell S.

AU - Gonugunta, Amrit S.

AU - Wang, Yiqing

AU - Sheffield, Thomas

AU - Lu, Rong

AU - Ali, Sadia

AU - Fattah, Farjana J.

AU - Xie, Donglu

AU - Cai, Jennifer

AU - Xie, Yang

AU - Gerber, David E.

PY - 2022/9

Y1 - 2022/9

N2 - The article Divergent prognostic effects of pre‑existing and treatment‑emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors, written by Mitchell S. von Itzstein, Amrit S. Gonugunta, Yiqing Wang, Thomas Sheffield, Rong Lu, Sadia Ali, Farjana J. Fattah, Donglu Xie, Jennifer Cai, Yang Xie and David E. Gerber, was originally published electronically on the publisher’s internet portal on 24 January 2022 without open access.

AB - The article Divergent prognostic effects of pre‑existing and treatment‑emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors, written by Mitchell S. von Itzstein, Amrit S. Gonugunta, Yiqing Wang, Thomas Sheffield, Rong Lu, Sadia Ali, Farjana J. Fattah, Donglu Xie, Jennifer Cai, Yang Xie and David E. Gerber, was originally published electronically on the publisher’s internet portal on 24 January 2022 without open access.

UR - http://www.scopus.com/inward/record.url?scp=85130292802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85130292802&partnerID=8YFLogxK

U2 - 10.1007/s00262-022-03218-0

DO - 10.1007/s00262-022-03218-0

M3 - Comment/debate

C2 - 35596002

AN - SCOPUS:85130292802

SN - 0340-7004

VL - 71

SP - 2183

EP - 2184

JO - Cancer Immunology, Immunotherapy

JF - Cancer Immunology, Immunotherapy

IS - 9

ER -

Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors (Cancer Immunology, Immunotherapy, (2022), 71, 9, (2169-2181), 10.1007/s00262-022-03151-2)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this